FLUOCINOLONE TOPICAL AND OTIC DOSAGE FORMS
- Section 524.981 - Reserved
- Section 524.981a - Fluocinolone cream
- Section 524.981b - Fluocinolone solution
- Section 524.981c - Fluocinolone and neomycin cream
- Section 524.981d - Fluocinolone and dimethyl sulfoxide solution
- Section 524.981e - Fluocinolone and dimethyl sulfoxide otic solution
- Section 524.998 - Fluralaner
- Section 524.1001 - Fluralaner and moxidectin
- Section 524.1005 - Furazolidone powder
- Section 524.1044 - Gentamicin ophthalmic and topical dosage forms
- Section 524.1044a - Gentamicin ophthalmic solution
- Section 524.1044b - Gentamicin and betamethasone otic solution
- Section 524.1044c - Gentamicin ophthalmic ointment
- Section 524.1044d - Gentamicin and betamethasone ointment
- Section 524.1044e - Gentamicin spray
- Section 524.1044f - Gentamicin and betamethasone spray
- Section 524.1044g - Gentamicin, betamethasone, and clotrimazole ointment
- Section 524.1044h - Gentamicin, mometasone, and clotrimazole otic suspension
- Section 524.1044i - Gentamicin and betamethasone ophthalmic solution
- Section 524.1132 - Hydrocortisone, miconazole, and gentamicin otic suspension
- Section 524.1140 - Imidacloprid and ivermectin
- Section 524.1146 - Imidacloprid and moxidectin
- Section 524.1193 - Ivermectin topical solution
- Section 524.1195 - Ivermectin otic suspension
- Section 524.1200 - Kanamycin ophthalmic and topical dosage forms
- Section 524.1200a - Kanamycin ophthalmic ointment
- Section 524.1200b - Kanamycin ophthalmic solution
- Section 524.1204 - Kanamycin, amphomycin, and hydrocortisone ointment
- Section 524.1240 - Levamisole
- Section 524.1376 - 2-Mercaptobenzothiazole solution
- Section 524.1443 - Miconazole
- Section 524.1445 - Miconazole, polymixin B, and prednisolone suspension
- Section 524.1446 - Milbemycin otic solution
- Section 524.1448 - Mirtazapine transdermal ointment
- Section 524.1450 - Moxidectin
- Section 524.1465 - Mupirocin
- Section 524.1484 - Neomycin ophthalmic and topical dosage forms
- Section 524.1484b - Neomycin, isoflupredone, and tetracaine powder
- Section 524.1484c - Neomycin, isoflupredone, and tetracaine ointment
- Section 524.1484d - Neomycin, hydrocortisone, and tetracaine otic ointment
- Section 524.1484e - Neomycin and polymyxin B ophthalmic solution
- Section 524.1484f - Neomycin, prednisolone, and tetracaine otic suspension
- Section 524.1484g - Neomycin, thiabendazole, and dexamethasone solution
- Section 524.1484h - Neomycin, penicillin, polymyxin B, and hydrocortisone suspension
- Section 524.1484i - Neomycin and hydrocortisone ointment
- Section 524.1484k - Neomycin and prednisolone suspension
- Section 524.1580 - Nitrofurazone topical dosage forms
- Section 524.1580a - Nitrofurazone ointment
- Section 524.1580b - Nitrofurazone soluble powder
- Section 524.1580c - Nitrofurazone and butacaine ointment
- Section 524.1600 - Nystatin ophthalmic and topical dosage forms
- Section 524.1600a - Nystatin, neomycin, thiostrepton, and triamcinolone ointment
- Section 524.1600b - Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment
- Section 524.1610 - Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension
- Section 524.1662 - Oxytetracycline ophthalmic and topical dosage forms
- Section 524.1662a - Oxytetracycline and hydrocortisone spray
- Section 524.1662b - Oxytetracycline and polymyxin B ophthalmic ointment
- Section 524.1742 - Phosmet emulsifiable liquid
- Section 524.1982 - Proparacaine ophthalmic solution
- Section 524.2080 - Ropinirole
- Section 524.2098 - Selamectin
- Section 524.2099 - Selamectin and sarolaner
- Section 524.2101 - Selenium disulfide suspension
- Section 524.2338 - Terbinafine and betamethasone acetate
- Section 524.2350 - Tolnaftate cream
- Section 524.2482 - Triamcinolone spray
- Section 524.2483 - Removed
- Section 524.2620 - Liquid crystalline trypsin, Peru balsam, castor oil